Dexamethasone Palmitate for PONV After Open Surgery
NCT06997419 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2025-09-23
Summary
Dexamethasone is almost one of the most commonly used drugs for postoperative nausea and vomiting (PONV) prevention. However, PONV is still a complex problem to be solved; for example, even with preoperative dexamethasone administration, there are still some patients still experience PONV within 24 hours postoperatively. Compared to dexamethasone, dexamethasone palmitate has a long-lasting anti-inflammatory effect, 2-5 times that of traditional water-soluble dexamethasone, with fewer adverse effects. This trial aims to assess the effect and safety of preoperative dexamethasone palmitate on PONV after open surgery.
Conditions
- Postoperative Nausea and Vomiting
- Dexamethasone Palmitate
- Open Surgery
Interventions
- DRUG
-
Dexamethasone Palmitate
Patients in the dexamethasone palmitate group will be assigned to receive intravenous injection of dexamethasone palmitate 8 mg (contains 5mg dexamethasone) after anesthesia induction and before surgical incision.
- DRUG
-
Patients in the dexamethasone group will be assigned to receive intravenous injections of dexamethasone 5 mg after anesthesia induction and before surgical incision.
Sponsors & Collaborators
-
Beijing Tiantan Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-01
- Primary Completion
- 2026-11-30
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Dexamethasone Compared to Ondansetron and Dexamethasone for Prophylaxis of Postoperative Vomiting in Children
NCT01297010 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer Surgery
NCT01548209 ·Status: COMPLETED ·Phase: NA
-
Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery
NCT01007500 ·Status: COMPLETED ·Phase: PHASE4
-
Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
NCT01370408 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
NCT00104403 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Dexamethasone in Postoperative Symptoms After Mastectomy for Breast Cancer
NCT01116713 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin
NCT04201769 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
NCT00437229 ·Status: COMPLETED ·Phase: PHASE1
-
Dexamethasone Dose for Postoperative Nausea and Vomiting Prophylaxis in Obese Patients
NCT04538820 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery
NCT05408676 ·Status: COMPLETED ·Phase: NA
-
Palonosetron Associated to Aprepitant in Prophylaxis of PONV
NCT02431286 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation
NCT00314743 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
NCT00366834 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery
NCT01013012 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-emetic Prophylaxis With or Without Dexamethasone
NCT05242874 ·Status: COMPLETED ·Phase: PHASE3
-
Antiemetic Efficacy and Safety of Dexamethasone in Obstetric Surgical Patients
NCT01028547 ·Status: COMPLETED ·Phase: NA
-
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)
NCT00687011 ·Status: COMPLETED ·Phase: PHASE4
-
Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin
NCT01093690 ·Status: COMPLETED ·Phase: NA
-
Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV
NCT04437017 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
NCT01339260 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
NCT00601172 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
NCT01074697 ·Status: COMPLETED ·Phase: PHASE3
-
Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients
NCT04508400 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
NCT01376297 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer
NCT00343863 ·Status: COMPLETED ·Phase: NA